warnings
WARNINGS Mupirocin Ointment USP, 2% is not for ophthalmic use.
mupirocin
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- mupirocin
- Generic name
- MUPIROCIN
- Manufacturer
- Proficient Rx LP
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 97f8d67d-c422-4a26-9394-24a5ec9719d9
- SPL ID
- a0ee6d21-0deb-4308-9af0-314574a04072
- Version
- 8
- Effective date
- 2022-04-01
- Source export date
- 2026-09-28
- Source partition
- 1
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/9c7783846d422acb0c9e59457606951c785a7d28cc631c8cc4839d0dc7c55f39/drug-label-0001-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:14:03
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | ANDA | 065123 | derived:openfda.application_number |
| application number | ANDA065123 | openfda.application_number | |
| brand name | mupirocin | openfda.brand_name | |
| generic name | MUPIROCIN | openfda.generic_name | |
| manufacturer name | Proficient Rx LP | openfda.manufacturer_name | |
| ndc | package | 63187-261-22 | openfda.package_ndc |
| ndc | product | 63187-261 | openfda.product_ndc |
| ndc11 | package | 63187026122 | derived:openfda.package_ndc |
| rxcui | 106346 | openfda.rxcui | |
| spl id | a0ee6d21-0deb-4308-9af0-314574a04072 | id | |
| spl set id | 97f8d67d-c422-4a26-9394-24a5ec9719d9 | set_id | |
| unii | D0GX863OA5 | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS The following local adverse reactions have been reported in connection with the use of mupirocin ointment USP, 2%: Burning, stinging, or pain in 1.5% of patients; itching in 1% of patients; rash, nausea, erythema, dry skin, tenderness, swelling, contact dermatitis, and increased exudate in less than 1% of patients. Systemic reactions to mupirocin ointment USP, 2% have occurred rarely.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.